Cadaver bone used in dental implants comes from deceased human donors whose tissue is recovered by licensed tissue banks, much like organ donation. The bone is harvested, processed to remove all living cells, and sterilized before it reaches your dentist’s office in a small vial of granules. By the time it’s placed in your jaw, it no longer contains any living donor cells. It serves purely as a scaffold that your own bone gradually replaces.
How Donors Are Selected
Tissue banks source bone from two types of donors. Cadaver donors, who provide the bulk of bone used in dentistry, can supply material from nearly any segment of the skeleton and tend to be younger individuals with higher-quality bone tissue. Live donors, by contrast, contribute femoral heads removed during hip replacement surgery, which yields a much smaller quantity of usable material.
Before any tissue is recovered, the donor goes through a thorough screening process. Harvesting teams registered with transplantation centers review the donor’s full medical history and lifestyle habits. Donors are tested for HIV, hepatitis B, hepatitis C, and tuberculosis, among other infections. Specific disqualifying criteria exist: a history of active tuberculosis, a positive TB test within the past two years, or close contact with someone who had TB disease. For tissue products that retain living cells, donors over 65 are also excluded. Family authorization is required before any harvesting takes place, similar to the consent process for organ donation.
From Donor Bone to Dental Graft Material
Once recovered, the bone undergoes extensive processing at the tissue bank. The goal is twofold: strip away everything biological from the donor (cells, blood, marrow, potential pathogens) while preserving the mineral structure that makes bone useful as a building framework.
Two main forms of processed bone end up in dental offices. Freeze-dried bone allograft (FDBA) retains its mineral content and acts primarily as a physical scaffold. Your bone-building cells crawl across its surface and use it as a framework to lay down new bone. Demineralized freeze-dried bone allograft (DFDBA) goes a step further: the mineral component is chemically removed, exposing proteins embedded in the bone matrix, including growth factors that can actively stimulate new bone formation. Both forms have been used successfully in dental procedures, though clinical studies have found similar outcomes between the two for treating bone defects around teeth.
Sterilization typically involves gamma irradiation, often performed while the tissue is packed in dry ice. A Belgian tissue bank documented an eight-step processing protocol that can either remove or inactivate viral loads if present. When tissue processing is performed on a donor who already tested negative at the time of donation, the calculated risk of viral transmission drops to less than one in 20 trillion, a number so small it’s effectively zero. That risk is far lower than most other risks associated with any surgical procedure.
How Cadaver Bone Works in Your Jaw
Your body treats the processed donor bone as a temporary framework, not a permanent implant. Bone tissue has the ability to regenerate completely when given a defined space to grow into. After your dentist packs the graft material into a socket or defect site, your own bone-building cells (osteoblasts) migrate from the edges of the surrounding bone onto the graft particles. They use the donor bone as scaffolding, gradually depositing new living bone while the graft material is absorbed and broken down. Over several months, your natural bone generally replaces the graft material completely, leaving behind a fully integrated region of new bone strong enough to support an implant.
This process, called osteoconduction, is the minimum requirement for any bone graft material. The donor bone also acts as a mineral reservoir, releasing calcium and phosphate that contribute to new bone formation as it dissolves.
Success Rates With Cadaver Bone
Dental implants placed in bone rebuilt with cadaver allografts perform well. A retrospective study found implant survival of 94.9% and graft success of 92.3% at allograft sites. That trails autografts (the patient’s own bone) only slightly, at 96.4%, and is comparable to bovine xenografts at 95.5% implant survival.
One notable advantage of allografts over xenografts is the amount of new bone they generate. Research comparing the two found 65% newly formed bone at allograft sites versus 45% at xenograft sites. Allografts also leave behind fewer residual graft particles (an average of 27% remaining) compared to xenografts (41%), meaning more of the cadaver bone gets replaced by your own living tissue. The trade-off is that allografts tend to resorb faster, which in some situations means slightly more volume loss in the months after grafting.
How Cadaver Bone Compares to Other Options
Your dentist may offer several graft material choices, each with distinct characteristics.
- Autograft (your own bone): Harvested from another site in your mouth or body. Considered the gold standard because it contains your own living cells, growth factors, and mineral structure all at once. The downside is a second surgical site, which means additional pain, healing time, and potential complications.
- Allograft (cadaver bone): No second surgical site needed. Generates substantial new bone growth and is largely resorbed and replaced by your own tissue. Carries a theoretical, though vanishingly small, risk of disease transmission after modern processing.
- Xenograft (animal bone, usually bovine): Most commonly sourced from cows. Resorbs very slowly, which helps maintain volume long-term but means more residual graft particles stay in your jaw rather than being fully replaced by living bone. Some patients reject this option on religious grounds: in one study from Saudi Arabia, 63% of participants declined porcine (pig) bone grafts and 41% declined bovine grafts due to religious beliefs, while only 13.5% declined human allografts for the same reason.
- Alloplast (synthetic bone): Manufactured materials like calcium phosphate ceramics. No biological origin at all, which eliminates disease transmission concerns entirely. Had the lowest religious objection rate at 10.5%.
Regulation and Oversight
In the United States, human tissue for transplantation is regulated by the FDA under rules that classify bone grafts as human cells, tissues, and cellular and tissue-based products. Tissue banks that process and distribute allograft bone must register with the FDA and follow current good tissue practice requirements covering donor screening, processing, storage, and distribution. Many also seek voluntary accreditation from the American Association of Tissue Banks, which imposes additional standards above the federal baseline.
Every step in the chain, from donor identification through final packaging, is documented and traceable. If you receive a cadaver bone graft, your dentist’s records will include the lot number and tissue bank of origin, so the graft can be traced back to its source if any safety concern ever arises.

